These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35291846)

  • 1. [Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge].
    Benz R
    Ther Umsch; 2022; 79(2):107-113. PubMed ID: 35291846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in myelodysplastic/myeloproliferative neoplasms.
    Prakash S; Arber DA; Bueso-Ramos C; Hasserjian RP; Orazi A
    Virchows Arch; 2023 Jan; 482(1):69-83. PubMed ID: 36469102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.
    Kuendgen A; Kasprzak A; Germing U
    Front Oncol; 2021; 11():778741. PubMed ID: 34869027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDS/MPN-RS-T justified inclusion as a unique disease entity?
    Montalban-Bravo G; Garcia-Manero G
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101147. PubMed ID: 32460979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
    Loghavi S; Wang SA
    Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
    Savona MR; Malcovati L; Komrokji R; Tiu RV; Mughal TI; Orazi A; Kiladjian JJ; Padron E; Solary E; Tibes R; Itzykson R; Cazzola M; Mesa R; Maciejewski J; Fenaux P; Garcia-Manero G; Gerds A; Sanz G; Niemeyer CM; Cervantes F; Germing U; Cross NC; List AF;
    Blood; 2015 Mar; 125(12):1857-65. PubMed ID: 25624319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
    Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
    Sangiorgio VFI; Orazi A; Arber DA
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
    Mangaonkar AA; Lasho TL; Ketterling RP; Reichard KK; Gangat N; Al-Kali A; Begna KH; Pardanani A; Al Ali NH; Talati C; Sallman D; Padron E; Patnaik MM; Tefferi A; Komrokji R
    Blood Cancer J; 2022 Feb; 12(2):26. PubMed ID: 35105856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.
    Li Y; Beck RC; Moore EM
    Am J Clin Pathol; 2021 Sep; 156(4):634-643. PubMed ID: 33877292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future.
    Nathan DI; Feld J; El Jamal SM; Mascarenhas J; Tremblay D
    Leuk Res; 2022 Apr; 115():106820. PubMed ID: 35279478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates.
    Geyer JT; Orazi A
    Int J Lab Hematol; 2016 May; 38 Suppl 1():12-9. PubMed ID: 27161873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
    Liu YC; Illar GM; Bailey NG
    J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.
    Yin CC; Medeiros LJ; Bueso-Ramos CE
    Int J Lab Hematol; 2010 Oct; 32(5):461-76. PubMed ID: 20626469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
    Leguit RJ; Orazi A; Kucine N; Kvasnicka HM; Gianelli U; Arber DA; Porwit A; Ponzoni M
    Virchows Arch; 2022 Oct; 481(4):621-646. PubMed ID: 35819517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mutations associated with blood count abnormalities in myeloid neoplasms.
    Polprasert C; Kongkiatkamon S; Niparuck P; Rattanathammethee T; Wudhikarn K; Chuncharunee S; Kobbuaklee S; Suksusut A; Lanamtieng T; Lawasut P; Asawapanumas T; Bunworasate U; Rojnuckarin P
    Hematology; 2022 Dec; 27(1):765-771. PubMed ID: 35766510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.